Company ReportsA - Companies

Amgen, Inc.

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $175 59 Pages MarketLine November, 2015 MTLN5797628
Lowest Prices Guaranteed
Price from $175
Length 59 Pages
Publisher MarketLine
Published Date November, 2015
SKU MTLN5797628

Amgen, Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Amgen, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
  • Intelligence on Amgen, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Amgen, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Amgen (or 'the company') is a biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 17,900 people as on December 31, 2014.Reasons to Purchase:

  • Gain understanding of Amgen, Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Amgen, Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Amgen, Inc.’s business structure, strategy and prospects


    • Company Snapshot
    Amgen, Inc.: Company Overview
    Amgen, Inc.: Overview and Key Facts
    Amgen, Inc.: Overview
    Amgen, Inc.: Key Facts
    Amgen, Inc.: Key Employees
    Amgen, Inc.: Key Employee Biographies
    Amgen, Inc.: Major Products and Services
    Amgen, Inc.: Company History
    Amgen, Inc.: Management Statement
    Amgen, Inc.: Locations and Subsidiaries
    Amgen, Inc.: Key Competitors
    Amgen, Inc.: Company Analysis
    Amgen, Inc.: Business Description
    Amgen, Inc.: SWOT Analysis
    Amgen, Inc.: SWOT Overview
    Amgen, Inc.: Strengths
    Amgen, Inc.: Weaknesses
    Amgen, Inc.: Opportunities
    Amgen, Inc.: Threats
    Amgen, Inc.: Corporate Financial Deals Activity
    Amgen, Inc.: Financial Deals Overview
    Amgen, Inc.: Targets and Partners
    Amgen, Inc.: Top Deals 2011 - 2015YTD*
    Amgen, Inc.: Advisors
    Amgen, Inc.: Top Legal Advisors
    Amgen, Inc.: Top Financial Advisors
    Amgen, Inc.: Mergers and Acquisitions
    Amgen, Inc.: Partnership
    Amgen, Inc.: Divestments
    Amgen, Inc.: Recent Developments
    Amgen, Inc.: News and Events Summary
    Amgen, Inc.: Business Expansion
    Amgen, Inc.: Contracts
    Amgen, Inc.: Financial Deals
    Amgen, Inc.: Financial Performance
    Amgen, Inc.: Regulatory and Legal Events
    Amgen, Inc.: Research & Development
    Amgen, Inc.: Strategy and Operations
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Amgen, Inc.: Key Facts
    Table 2: Amgen, Inc.: Key Employees
    Table 4: Amgen, Inc.: Key Competitors
    Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
    Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
    Table 9: Amgen, Inc.: Targets and Partners
    Table 10: Amgen, Inc.: Top Deals 2011 - 2015YTD*
    Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
    Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
    Table 13: Amgen, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 14: Amgen, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Table 15: Amgen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 16: Amgen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 17: Amgen, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Table 18: Amgen, Inc.: Divestments by Geography (2011 - YTD*2015)
    Table 19: Amgen, Inc.: News and Events Summary
    Table 20: Amgen, Inc.: Business Expansion
    Table 21: Amgen, Inc.: Contracts
    Table 22: Amgen, Inc.: Financial Deals
    Table 23: Amgen, Inc.: Financial Performance
    Table 24: Amgen, Inc.: Regulatory and Legal Events
    Table 25: Amgen, Inc.: Research & Development
    Table 26: Amgen, Inc.: Strategy and Operations
    List of Figures
    Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
    Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
    Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 6: Amgen, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Figure 7: Amgen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 8: Amgen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 9: Amgen, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Figure 10: Amgen, Inc.: Divestments by Geography (2011 - YTD*2015)

    $175
    $437.50
     
    Research assistance
    US: 800.298.5699
    Int'l: +1.240.747.3093
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks